BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang P, Xu M, Han H, Zhao X, Li MD, Yang Z. Integrative Analysis of Epigenome and Transcriptome Data Reveals Aberrantly Methylated Promoters and Enhancers in Hepatocellular Carcinoma. Front Oncol 2021;11:769390. [PMID: 34858848 DOI: 10.3389/fonc.2021.769390] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Jihad M, Yet İ. Multiomics Integration at Single-Cell Resolution Using Bayesian Networks: A Case Study in Hepatocellular Carcinoma. OMICS 2023;27:24-33. [PMID: 36602810 DOI: 10.1089/omi.2022.0170] [Reference Citation Analysis]
2 Bizet M, Defrance M, Calonne E, Bontempi G, Sotiriou C, Fuks F, Jeschke J. Improving Infinium MethylationEPIC data processing: re-annotation of enhancers and long noncoding RNA genes and benchmarking of normalization methods. Epigenetics 2022;17:2434-2454. [DOI: 10.1080/15592294.2022.2135201] [Reference Citation Analysis]
3 Huang S, Chen S, Zhang D, Gao J, Liu L. Enhancer-associated regulatory network and gene signature based on transcriptome and methylation data to predict the survival of patients with lung adenocarcinoma. Front Genet 2022;13:fgene-2022-1008602. [DOI: 10.3389/fgene.2022.1008602] [Reference Citation Analysis]
4 Huang P, Zhang B, Zhao J, Li MD. Integrating the Epigenome and Transcriptome of Hepatocellular Carcinoma to Identify Systematic Enhancer Aberrations and Establish an Aberrant Enhancer-Related Prognostic Signature. Front Cell Dev Biol 2022;10:827657. [PMID: 35300417 DOI: 10.3389/fcell.2022.827657] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Weisenberger DJ, Lakshminarasimhan R, Liang G. The Role of DNA Methylation and DNA Methyltransferases in Cancer. Advances in Experimental Medicine and Biology 2022. [DOI: 10.1007/978-3-031-11454-0_13] [Reference Citation Analysis]